Beyond Blood Sugar: Why Type 1 Diabetes Affects the Heart, Liver, and Kidneys

Most people think of Type 1 diabetes as a problem with blood sugar control. But researchers are now recognizing that insulin resistance—when the body does not respond well to insulin—can also occur in people with Type 1 diabetes. This creates a double challenge: the pancreas cannot make enough insulin, and the body's cells do not use insulin effectively.

Insulin resistance in Type 1 diabetes is linked to damage in multiple organs, including the liver, kidneys, and heart. This damage can happen even when blood sugar levels are in target range, which means standard blood sugar monitoring alone may not catch these problems early.

People with Type 1 diabetes receive insulin through shots or pumps under the skin. Research suggests this method of delivery may affect how the body processes insulin and stores fat. When insulin is delivered subcutaneously—rather than into the bloodstream directly—it changes the balance of insulin in the liver and the rest of the body.

This imbalance can trigger the body to store fat in problematic ways and reduce how well cells respond to insulin signals. Over time, these changes may set the stage for organ damage.

Insulin resistance in Type 1 diabetes is connected to metabolic dysfunction-associated steatotic liver disease—a condition in which fat builds up in liver cells. The liver also becomes insulin resistant, which worsens the problem and can lead to liver injury over time.

The kidneys are affected too. Excess insulin can cause the kidneys to filter blood too aggressively and become more leaky, which may damage delicate kidney structures and affect kidney function.

The heart faces additional stress from visceral fat (fat around organs) and unhealthy cholesterol patterns that accelerate aging of blood vessels. Research shows that teenagers and young adults with Type 1 diabetes may already show subtle signs of heart dysfunction, even though they have no symptoms.

Because insulin resistance and organ damage can develop silently, researchers recommend that care for Type 1 diabetes expand beyond blood sugar management alone. This approach—called the Cardiovascular-Kidney-Metabolic framework—involves checking for insulin sensitivity, screening the liver for fat buildup, and evaluating heart health.

The goal is to catch problems early and consider medications or other interventions that address insulin resistance directly, not just blood sugar control. This more comprehensive approach may help prevent serious complications and preserve long-term health.

Source: Endocrinology and metabolism clinics of North America. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.